In case a higher dose is required and recommended by your provider throughout your program, you can take advantage of our high dose membership program as follows: Tirzepatide: For most states, our high dose membership offers up to 15mg/week (as medically appropriate) for an additional $150 per month
This delay contrasts with tirzepatide, which is currently accessible in the United States and has recently obtained approval in Europe.217 Adverse Reactions and Safety of GLP-1RAs and GLP-1/GIP Dual Receptor Agonist GLP-1RAs and dual agonists targeting GLP-1 and GIP receptors have demonstrated considerable efficacy in the treatment of T2DM and obesity
Kaku K, Haneda M, Tanaka Y, et al
Clinical trials have shown that tirzepatide (Mounjaro, Zepbound) generally leads to greater weight loss compared to semaglutide (Ozempic, Wegovy)
Always consult with a healthcare professional for personalized guidance